Labiotech.eu

msd cancer research uk monash crt merck australia

News and Trends 1 Feb 2016

New Discovery unites Australia, Germany and UK Against Blood Cancers

Cancer Research UK has teamed up with MSD (Merck) and the Wellcome Trust to co-develop some Inhibitors for both Cancerous and Non-cancerous blood disorders from the Australian Academia-Biotech Network. The Australian Co-operative Research Centre (CRC) for Cancer Therapeutics (CTx) in Melbourne has a range of investigational inhibitors for blood disorders – including Leukemia. CTx is collaborative partnership […]

February 1, 2016 - 2 minutesmins - By Dani Bancroft

oxford biotech biomedica novartis car t cancer

News and Trends 1 Feb 2016

World CAR-T Leader Starts New Program with a UK Biotech

Pretty impressive CAR-T news coming from across the Channel… Oxford BioMedica just launched a second collaboration with Novartis, which has shown tremendous Phase II results – and the most advanced in CAR-T therapy in development so far (read our review on how CAR-T works and who else is working the field). This collaboration covers the […]

February 1, 2016 - 2 minutesmins - By Philip Hemme

News and Trends 30 Jan 2016

What happened this week? 5 Fantastic Biotech Years, Galapagos, Biotech on French TV

Monday: Nature’s Machines: Biohacking Evolution to Destroy Pollutants Tuesday: 2011-2015: What a Fantastic 5 Years for European Biotech Wednesday: French Investor Leads €60M Financial Round for the Future of DNA Synthesis Thursday: This Young CEO is Making Biotech Popular in France Friday: Pei-Ying Lin’s BioArt: Stunning Smallpox, Nutritious NanoFood and Microbial Fractals Bonus: 10 Interesting European […]

January 30, 2016 - 1 minutemin - By Philip Hemme

pei ying lin smallpox syndrome bioart uk

News and Trends 29 Jan 2016

Pei-Ying Lin’s BioArt: Stunning Smallpox, Nutritious NanoFood and Microbial Fractals

Pei-Ying Lin founded the Taiwanese BioArt community with her Science-Humanities and programming background to tackle complex BioArt statements all across the EU. Lin is a Scientist-turned-artist, with her fascination in BioArt having stemmed from a Life Sciences degree from the National Tsing Hua University in Taiwan and a Masters at the Royal College of Art in London. She’s also […]

January 29, 2016 - 2 minutesmins - By Dani Bancroft

News and Trends 29 Jan 2016

Biotech of the week: Vivia Biotech, the Spanish Pioneer in Personalised Medicine

This week we leave the cold winds of Sweden and head south, to warmer weather and say ¡Hola! to Spain and the location for this week, Madrid. This vibrant city is famous for one of the best football teams in the world, the oldest restaurant in the world (opened in 1725!) and is home to the […]

January 29, 2016 - 2 minutesmins - By Philip Hemme

News and Trends 28 Jan 2016

This Young CEO is Making Biotech Popular in France

Biotech is often a touchy subject for conversation, which is not always understood by the general public, and even less appreciated… Xavier Duportet, the 28-year-old French founder of Eligo Bioscience (read Our interview here) was this week on the hugely popular French TV-show Le Petit Journal to talk about Biotech. This program is the most popular such medium […]

January 28, 2016 - 2 minutesmins - By Philip Hemme

karolinska microbiome ferring pharma research scilifelab

News and Trends 28 Jan 2016

Sweden and Switzerland Join in on Microbiome Hype with New Karolinska Research Centre

Ferring Pharmaceuticals (Switzerland) and the Karolinska Institutet (Sweden) announce a collaboration on a new research centere exploiting the human microbiome. The Karolinska Institutet has a deep understanding of the human microbiome, and the institute actually accounts for over 40% of the medical academic research conducted in Sweden (not to mention their long-standing ties with the Nobel Prize […]

January 28, 2016 - 2 minutesmins - By Dani Bancroft

News and Trends 28 Jan 2016

Viral Immunotherapy Trial Failure Causes French Biotech Stocks to Drop 43%

Genticel (France) is a clinical biotech developing a cervical cancer immunotherapy against the Human papillomavirus. However, their 24-month phase II trial has failed to meet primary endpoint at its halfway point, and their stocks dropped 43% overnight. Around 70% of cervical cancer cases are caused by 2 types of Human papillomavirus (HPV): 16 and 18. And among the 300 million women around the […]

January 28, 2016 - 3 minutesmins - By Dani Bancroft

Twist dna bioscience sequencing micrarray emily leproust

News and Trends 27 Jan 2016

French Investor Leads €60M Financial Round for the Future of DNA Synthesis

Twist Bioscience is a San Francisco Biotech accelerating science and innovation through rapid, high-quality DNA synthesis piece of tech. And now, Twist has completed a $61 million Series D round. An improved silicon-based design compared to the traditional 96-well plates could do wonders for DNA synthesis, including major improvements in cost and time of the process. And the […]

January 27, 2016 - 3 minutesmins - By Dani Bancroft

cambridge gsk ucl imperial apollo jj astrazeneca

News and Trends 27 Jan 2016

New UK Joint Venture Bridges Gap between Top Universities and Big Pharmas

AstraZeneca, GlaxoSmithKline, Johnson & Johnson and the 3 world-leading universities (Imperial College London, University College London and the University of Cambridge) have joined forces to found the ‘Apollo’ Bridge. This pioneering new joint venture, the Apollo Therapeutics Fund, will support the translation of ground-breaking academic science from within these universities into innovative new medicines for […]

January 27, 2016 - 3 minutesmins - By Dani Bancroft

News and Trends 27 Jan 2016

3 Facts Showing that the Future of Biotech Media is Online

Print Media are having a hard time since the explosion of digital content. In Biotech, publishers are facing the same challenge. As a leading Biotech publication, we believe that the future of our field is online. Here are some explanations on why we think so! The first thing to look at is how the content consumption has […]

January 27, 2016 - 2 minutesmins - By Joachim Eeckhout

merck msd keytruda immunoncology lymphoma hodgkins affimed

News and Trends 26 Jan 2016

Keytruda Combo! MSD Recruits German Biotech on Lymphoma PD-1 Trial

Affimed in Heidelberg (Germany) will fund and conduct a clinical trial to investigate the combination of Merck’s (MSD) anti-PD-1 therapy (Keytruda), with Affimed’s proprietary drug for the treatment of patients with Hodgkin lymphoma. The phase Ib trial will focus on patients whose disease has relapsed or is refractory to chemotherapy, including treatment with the marketed antibody-drug-conjugate […]

January 26, 2016 - 2 minutesmins - By Dani Bancroft

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

New Discovery unites Australia, Germany and UK Against Blood Cancers

World CAR-T Leader Starts New Program with a UK Biotech

What happened this week? 5 Fantastic Biotech Years, Galapagos, Biotech on French TV

Pei-Ying Lin’s BioArt: Stunning Smallpox, Nutritious NanoFood and Microbial Fractals

Biotech of the week: Vivia Biotech, the Spanish Pioneer in Personalised Medicine

This Young CEO is Making Biotech Popular in France

Sweden and Switzerland Join in on Microbiome Hype with New Karolinska Research Centre

Viral Immunotherapy Trial Failure Causes French Biotech Stocks to Drop 43%

French Investor Leads €60M Financial Round for the Future of DNA Synthesis

New UK Joint Venture Bridges Gap between Top Universities and Big Pharmas

3 Facts Showing that the Future of Biotech Media is Online

Keytruda Combo! MSD Recruits German Biotech on Lymphoma PD-1 Trial

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!